Tiotropium is efficacious in 6- to 17-year-olds with asthma, independent of T2 phenotype
The Journal of Allergy and Clinical Immunology: In Practice | Apr 24, 2019
Most read this week
The Journal of Allergy and Clinical Immunology: In Practice | Apr 24, 2019